EVLution Nutrition CLA1000®, Stimulant Free Weight Management, 90 Softgels (1,000 mg per Softgel)
UPC: 852687908601
EVLution Nutrition's CLA1000® is a stimulant-free softgel supplement formulated to support weight management and lean muscle maintenance. Each softgel provides 1,000 mg of a conjugated linoleic acid (CLA) blend, a type of polyunsaturated fatty acid that occurs naturally in some meat and dairy products.
The manufacturer states this product is designed to support a healthy metabolic rate as part of a balanced diet and exercise regimen. The recommended usage is one softgel taken with morning, noon, and evening meals, which aligns with the 90-count bottle providing a 30-day supply at the full serving size.
This product is manufactured in the USA in a GMP-registered facility. The softgel form is designed for easy swallowing, and the formula is gluten-free.
At a glance
Supplement Facts
| Ingredient | Amount Per Serving | % Daily Value |
|---|---|---|
| Calories | 10 | † |
| Calories from Fat | 10 | † |
| Total Fat | 1 g | 1% |
| Polyunsaturated fat | 0.75 g | † |
| CLA Blend | 1,000 mg | † |
| † Daily Value not established | ||
Other Ingredients
Gelatin, glycerin, purified water.
This product is made in the USA has been distributed and manufactured by a (GMP) registered facility and contains ingredients of domestic and international origin.
Certifications & Claims
Label Information
Directions, warnings, and other information directly from the product label.
Suggested Use
As a dietary supplement, consume 1 serving of CLA1000® with morning, noon, and evening meals or use as directed by a physician or licensed nutritionist.
Warning
Not for use by those with pre-existing medical conditions; those taking any medications, those under the age of 18 or women that are contemplating pregnancy, pregnant or nursing. Keep out of reach of children and pets.
Product Info
- Brand
- Evlution Nutrition
- UPC
- 852687908601
- Package Qty
- 90 count
- Dimensions
- 4.75 x 2.65 x 2.65 in
- Shipping Weight
- 0.36 lb
- First Available
- 01/2017
